BACKGROUND In response to pressure overload, the heart develops ventricular hypertrophy that progressively de-
C ardiac hypertrophy progressively decompensates and becomes maladaptive, leading to pathological cardiac remodeling and heart failure (1) . Maladaptive cardiac hypertrophy is accompanied by interstitial and perivascular fibrosis and by changes in cardiac metabolism. The hypertrophic heart progressively reverts to an embryonic metabolic program with reduced fatty acid oxidation and increased reliance on glucose metabolism that result in decreased ATP production (2) .
The calcium-regulated phosphatase calcineurin plays a major role in pathological hypertrophy. Calcineurin is composed of a catalytic (CnA) and a regulatory (CnB) subunit. CnA is encoded by 3 different genes (resulting in CnAa, CnAb, and CnAg), with CnAb being the main isoform in the heart. Two splice variants for CnAb have been described. Although
CnAb2 has a C-terminal autoinhibitory domain and acts like a typical CnA, CnAb1 has a unique C-terminal domain, not shared by any other known protein, that confers these isoform specific properties (3) (4) (5) (6) .
Constitutive activation of calcineurin or its main target, the transcription factor nuclear factor of activated T cells (NFATc), leads to massive maladaptive cardiac hypertrophy (7) . By contrast, mice lacking CnAb show reduced ventricular hypertrophy in response to pressure overload (8) . However, the role of CnAb1 in this context is unknown.
METHODS
Full Methods can be found in the Online Appendix.
MICE. aMHC-CnAb1 mice express the human CnAb1 isoform in a cardiomyocyte-restricted manner under the control of the alpha myosin heavy chain (aMHC) promoter (4) . CnAb1
Di12 mice were generated by deleting intron 12-13 in the gene that encodes CnAb (Ppp3cb), which encodes the unique C-terminal domain in CnAb1. Only adult male mice were used in this study. All procedures were approved by the ethics committees of the CNIC and the Regional Government of Madrid.
SURGERIES AND ECHOCARDIOGRAPHIC ANALYSIS.
Maladaptive cardiac hypertrophy was induced by transaortic constriction (TAC) trying to reproduce the human condition as much as possible (9) . Where indicated, L-buthionine-sulfoximine (BSO) All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Padrón-Barthe, Villalba-Orero, and Gómez-Salinero contributed equally to this work and are joint first authors. Robyn Shaw, MD, PhD, served as Guest Editor for this paper.
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WT αMHC-CnAβ1 WT αMHC-CnAβ1 with these results, we also observed reduced expression of the fibrosis markers collagen Ia1 (Col1a1) and lysyl oxidase (Lox) in CnAb1-overexpressing mice, together with reduced levels of SMAD2 phosphorylation, suggesting reduced TGF-b signaling (Online Figures 1E to 1G ).
To confirm the functional improvement elicited by CnAb1 in a second transgenic mouse line, we used rtTA-CnAb1 mice in which CnAb1 expression is induced w3-fold upon treatment with doxycycline (3). We found that CnAb1 overexpression significantly reduced the left ventricular mass and improved systolic function 42 days after TAC, confirming the results obtained in aMHC-CnAb1 mice (Online Figure 2) .
Together, these results demonstrate that CnAb1, unlike other calcineurin isoforms, reduces maladaptive hypertrophy and cardiac remodeling following pressure overload. CnAb1 ACTIVATES SERINE AND ONE-CARBON METABOLISM. We next analyzed the transcription profile of WT and transgenic mice using microarrays.
Following TAC, WT mice showed a consistent up-regulation of genes associated with extracellular matrix, cell adhesion, and fibrosis (Online Tables 1   and 2 ) and a down-regulation of genes associated with the mitochondria (Online Tables 3 and 4 We then carried out a quantitative proteomics analysis of sham WT and transgenic mice, which also showed a strong increase in proteins involved in the serine and one-carbon pathway in aMHC-CnAb1 mice (Online Table 17 , Figure 2D ), confirming that serine and one-carbon metabolism was strongly induced in the heart by CnAb1.
Many of these genes are regulated by the mTOR signaling pathway through the transcription factor activating transcription factor 4 (ATF4) (4,10). To determine whether this pathway was activated by CnAb1 in the context of pressure overload, we analyzed these proteins by Western blot. We observed activation of the mTOR/AKT signaling pathway and increased expression of ATF4 in CnAb1-overexpressing 
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CnAb1 Improves Function Through 1C Metabolism CnAb1 OVEREXPRESSION CHANGES THE HEART'S METABOLOME. Phdgh-derived serine synthesis and the one-carbon cycle supply metabolites for the production of antioxidant mediators such as glutathione (11, 12) . A thorough metabolomic analysis in uninjured WT and aMHC-CnAb1 mice detected a total of 462 different metabolites in myocardial samples from both mouse types, with 133 of them being upregulated in transgenic mice and 65 metabolites down-regulated (Online Table 18 To explore these changes more in depth, we analyzed the amount of different metabolites belonging to the affected pathways. We found a strong significant induction of glutathione, mainly reduced glutathione (GSH), and its precursor metabolites (Online Figures 4C and 5 , Online Table 18 ). This was accompanied by a significant induction of methionine metabolites (Online Figure 4D) . In addition, aMHC-CnAb1 mice showed a significant increase of several metabolites associated with polyamine metabolism and the urea cycle, mainly related to the degradation of arginine to ornithine, putrescine, and spermidine (Online Figure 4E , Online Table 18 ). We also found that several metabolites related to purine and pyrimidine metabolism were up-regulated, leading to a strong induction of the potent antioxidant urate (Online Table 18 ). These changes were mTOR ¼ mechanistic target of rapamycin; other abbreviations as in Figure 1 . Figure 4F) . Together, these changes indicated that CnAb1 activates several metabolic pathways with antioxidant activity.
MITOCHONDRIAL COMPLEXES SHOW INCREASED
ACTIVITY IN CnAb1-OVEREXPRESSING MICE. To determine whether the changes in the metabolic profile observed in transgenic mice would impact mitochondrial number or activity, we analyzed different parameters in uninjured mice. We first quantified mitochondrial DNA and found no significant differences between WT and aMHC-CnAb1 mice, although a small increase was observed in transgenic mice (Online Figure 6A) . Analysis of mitochondrial complexes and supercomplexes in isolated mitochondria revealed no differences between both mouse types (Online Figure 6B) . Similarly, we observed no obvious differences in the expression of individual complex components by Western blot (Online Figure 6C) . Analysis of the activity of the different mitochondrial complexes showed a significant increase in the activity of complexes IþIII and IIþIII in aMHC-CnAb1 mice (Online Figure 6D ). In addition, we observed increased citrate synthase activity in transgenic mice, in agreement with the increase in citrate detected by mass spectrometry (Online Table 18 ) and with the slight increase in mtDNA copy number (mitochondrial mass). These changes in the activity of mitochondrial complexes, however, had no effect on the production of ATP by isolated mitochondria, neither driven by glutamate and malate nor by succinate (Online Figure 6E) . heart. Using an enzymatic assay, we found an increase in GSH in aMHC-CnAb1 mice compared with WT, which was more evident 21 days after TAC ( Figure 4A ). We also found an increase in total glutathione in transgenic mice, albeit at much lower levels ( Figure 4B ). We observed a strong reduction in the production of ATP by mitochondria isolated from WT mice after TAC, both driven by glutamate and malate ( Figure 4C ) and by succinate ( Figure 4D ). By contrast, mitochondria from aMHC-CnAb1 mice showed preserved ATP production level after TAC, significantly higher than that of WT mice ( Figures 4C and 4D) . Figures 5A and 5B) .
Furthermore, NCT-503 prevented the improved ATP Figures 5C and 5D ). These data indicate that the serine and one-carbon pathway is necessary for the beneficial effects of CnAb1 on the heart.
GLUTATHIONE MEDIATES THE IMPROVED RESPONSE TO
PRESSURE OVERLOAD IN aMHC-CnAb1 MICE. To find out whether the increase in reduced glutathione was also responsible for the improvement in ATP production and cardiac function observed in aMHC-CnAb1 mice after TAC, we treated both WT and CnAb1 overexpressing mice with BSO, which decreases glutathione synthesis by inhibiting g-glutamylcysteine synthetase (15) . Administration of BSO resulted in a strong reduction in both GSH and total glutathione in both WT and transgenic mice, and prevented the increase in GSH induced by CnAb1 ( Figures 6A and 6B ). To determine the role of endogenous CnAb1, we developed knockout mice lacking intron 12-13 in the CnAb gene (CnAb1 Di12 mice), which codes for the LVMi (E) and LVEF (F) were determined by echocardiography in BSO-treated and untreated (control) mice 21 days after surgery. Note that the control (untreated) animals for these comparisons are those shown in Figure 1 , and are repeated here for comparative purposes. *p < 0.05, **p < 0.01, ***p < 0.005, TAC versus sham for each mouse line; †p < 0.05, † † †p < 0.005 aMHC-CnAb1 versus WT; ‡p < 0.05 BSO versus control; 2-way analysis of variance plus Bonferroni post-test. n ¼ 5 to 9 (A and B), n ¼ 3 to 9 (C and D), n ¼ 5 to 18 (E and F). Abbreviations as in Figures 1 and 4 .
Padrón-Barthe et al. 2-way analysis of variance plus Bonferroni post-test. Abbreviations as in Figures 1 and 4 .
CnAb1 Improves Function Through 1C Metabolism unique C-terminal domain in CnAb1 ( Figure 7A ).
Although these mice express no CnAb1, expression of the traditional isoform CnAb2 is unaltered ( Figures 7B and 7C ). CnAb1 Di12 mice are viable and fertile, and are born at the expected Mendelian ratio.
However, we observed a significant increase in car- CnAb1-deficient mice ( Figure 7H ). This reduced contractile capacity was paralleled by a decreased ability to produce ATP, both from glutamate and malate and from succinate ( Figures 7I and 7J) . CnAb1 activates mTOR and ATF4 to induce serine and one-carbon metabolism and promote the production of GSH, among other mediators.
Increased GSH results in reduced mitochondrial protein oxidation and increased ATP production, which improves cardiac function and remodeling after pressure overload. ATF4 ¼ activating transcription factor 4; ATP ¼ adenosine triphosphate; GbL ¼ G protein beta subunit-like; GSH ¼ reduced glutathione; mTOR ¼ mechanistic target of rapamycin.
Padrón-Barthe et al. Serine and one-carbon genes are known to be regulated by ATF4 upon activation of mTOR (10, 11, 21) .
These data, together with the inhibition of these genes by rapamycin in our transgenic mice, suggest that activation of the mTOR/ATF4 pathway by CnAb1 induces metabolic changes that allow the cardiomyocyte to obtain energy and NADH/NADPH through the serine and one-carbon pathway, decreasing mitochondrial protein oxidation and preserving ATP production after pressure overload (Central Illustration).
We also report here the first description of mice 
CONCLUSIONS
Our results demonstrate that CnAb1 has an opposite effect on the heart to that of other calcineurin iso- 
